Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adult Solid Neoplasm × temsirolimus × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 PRETEXT I Hepatoblastoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Adult Solid Neoplasm 1

Interventions

temsirolimus 1 ixabepilone 1 Sirolimus 1 Irinotecan 1 Erlotinib Hydrochloride 1 Epothilones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01375829 2026-03-18

Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Active not recruiting

Adult Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡